Torti Frank bought ROIV
December 23, 2025 · Form 4 insider transaction
Torti Frank bought 175,380 shares of Roivant Sciences Ltd. at $22.45 per share, a transaction worth $3.94M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
175,380
Price
$22.45
Total value
$3.94M
InsiderTorti Frank
RoleOfficer
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateDecember 23, 2025
Filing dateDecember 29, 2025
Shares owned after13,911,927
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.